Smartphone therapy could ease long COVID's mental toll

NCT ID NCT07714889

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests a coach-guided digital therapeutic called Toivoa-004, designed to help adults with Long COVID manage symptoms of anxiety and depression. The program delivers cognitive behavioral therapy through a smartphone app and is built to be accessible for people with disabilities. Researchers will measure how many participants complete at least 75% of the program over 12 weeks and track changes in mood scores.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a coach-delivered digital therapeutic platform (Toivoa-004) that provides cognitive behavioral therapy content via a smartphone app
What this could lead to
If successful, this could provide an accessible, scalable way to help people with Long COVID manage anxiety and depression symptoms.
What could go wrong
This is a very small early feasibility study (20 people) focused on engagement, not yet on effectiveness. The digital format may not suit everyone, and results may not generalize.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.